Elisabeth Cohen-Jonathan Moyal
Overview
Explore the profile of Elisabeth Cohen-Jonathan Moyal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
102
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Picca A, Di Stefano A, Savatovsky J, Ducray F, Chinot O, Moyal E, et al.
Neurooncol Adv
. 2024 May;
6(1):vdae068.
PMID: 38813112
Background: Oncogenic FGFR-TACC fusions are present in 3-5% of high-grade gliomas (HGGs). Fexagratinib (AZD4547) is an oral FGFR1-3 inhibitor with preclinical activity in FGFR-TACC+ gliomas. We tested its safety and...
2.
Bikfalvi A, Alves da Costa C, Avril T, Barnier J, Bauchet L, Brisson L, et al.
Trends Cancer
. 2023 Mar;
9(8):692.
PMID: 36997420
No abstract available.
3.
Montegut C, Guillamo J, Ducray F, Dehais C, Moyal E, Desenclos C, et al.
Cancers (Basel)
. 2022 Nov;
14(22).
PMID: 36428602
Background: Describe the characteristics, patterns of care, and predictive geriatric factors of elderly patients with IDHm high-grade glioma (HGG) included in the French POLA network. Material and Methods: The characteristics...
4.
Bikfalvi A, Alves da Costa C, Avril T, Barnier J, Bauchet L, Brisson L, et al.
Trends Cancer
. 2022 Nov;
9(1):9-27.
PMID: 36400694
Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has been recognized as an...
5.
Garnier L, Vidal C, Chinot O, Moyal E, Djelad A, Bronnimann C, et al.
Oncologist
. 2022 May;
27(5):414-423.
PMID: 35522558
Background: Anaplastic oligodendrogliomas IDH-mutant and 1p/19q codeleted (AO) occasionally have a poor outcome. Herein we aimed at analyzing their characteristics. Methods: We retrospectively analyzed the characteristics of 44 AO patients...